Company intelligence / Profile preview
Entourage Phytolab
São Paulo, São Paulo, Brazil
- Ownership
- Private
- Development stage
- Other
01
Overview
Entourage Phytolab has commercialized its Fusionner technology platform, which offers 53% more efficient cannabinoid absorption and up to 45% lower doses compared to other market products. The company has launched multiple products in both Brazilian and U.S. markets.
- Therapeutic areas
- Women's HealthImmunologyNeurologyPsychiatry
- Modalities
- Cannabinoid-based productsHemp extract
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Canopy GrowthBedrocan InternationalCannect
Beyond the preview
Go deeper on Entourage Phytolab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Entourage Phytolab.